Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$57,454,532
+$18,012,057 QoQ
Shares Held
1,197,718
+17.3% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALLIANCEBERNSTEIN L.P. holds $5,113,566,936 across 211 Biotechnology names. RPRX ranks #20 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,910,786 | $1,746,322,380 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
426,914 | $329,850,832 | |
| 3 | ARGX |
Argenx SE
|
422,304 | $308,387,496 | |
| 4 | GMAB |
Genmab A/S
|
9,557,149 | $256,418,307 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
1,908,907 | $141,755,433 | |
| 6 | TECH |
BIO-TECHNE Corp
|
2,213,197 | $115,661,675 | |
| 7 | INSM |
INSMED Inc
|
688,734 | $112,621,783 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,736,501 | $112,230,059 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $57,454,532 | 1,197,718 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $39,442,475 | 1,020,768 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $33,052,350 | 936,858 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $32,421,307 | 899,842 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $38,633,917 | 1,241,051 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $29,443,080 | 1,154,178 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $36,211,765 | 1,280,020 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $34,567,800 | 1,310,876 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $43,869,950 | 1,444,516 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $38,466,417 | 1,369,399 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,938,747 | 218,819 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,830,520 | 222,203 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $10,502,961 | 291,506 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,326,243 | 160,077 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $13,109,086 | 326,259 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $16,271,960 | 387,059 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $12,572,353 | 322,699 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,239,314 | 156,570 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,778,027 | 159,879 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $6,509,580 | 158,809 | Shares | Defined | 2021-07-30 | |
| 2021-03-31 | $4,060,454 | 93,087 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $2,511,108 | 50,172 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $1,712,753 | 40,712 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||